Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jing Xu Zhou"'
Autor:
Rui-Lian Chen, Ling-Ling Sun, Yang Cao, Han-Rui Chen, Jing-Xu Zhou, Chu-Ying Gu, Ying Zhang, Si-Yu Wang, Wei Hou, Li-Zhu Lin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCisplatin-based chemotherapy was previously considered as the standard adjuvant therapy for improved overall survival (OS) in patients with non-small cell lung cancer (NSCLC) after surgery. However, the benefit was limited due to high risks
Externí odkaz:
https://doaj.org/article/9d9f850dc1594d429f349a3aacfa8108
Autor:
Rui-Lian Chen, Jing-Xu Zhou, Yang Cao, Ling-Ling Sun, Shan Su, Xiao-Jie Deng, Jie-Tao Lin, Zhi-Wei Xiao, Zhuang-Zhong Chen, Si-Yu Wang, Li-Zhu Lin
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundLimited treatment strategies are available for squamous-cell lung cancer (SQLC) patients. Few studies have addressed whether immune-related genes (IRGs) or the tumor immune microenvironment can predict the prognosis for SQLC patients. Our s
Externí odkaz:
https://doaj.org/article/4199d2e347e04bdebbe5b92ab7e61560
Autor:
Wenping Wang, Jiayin Li, Zhiwei Xiao, Qiuye Yang, Jing Zhang, Hanrui Chen, Lizhu Lin, Jing-Xu Zhou
Publikováno v:
J Thorac Dis
Background Lung adenocarcinoma (LUAD) is the most common type of lung cancer. DNA repair genes (DRGs) is important in lung cancer. The relationship between the immune environment and the expression levels of DRGs in LUAD remains unclear. The purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6cb055a56b059037fc6c9624e3ce76
https://doi.org/10.21037/jtd-21-949
https://doi.org/10.21037/jtd-21-949
Autor:
Lizhu Lin, Jing-Xu Zhou, Yang Cao, Dong-Yan Lu, Peng Li, Yong-Hao Li, Mei Jiang, Sui-Hui Li, Rui-Lian Chen
Publikováno v:
Immunotherapy. 11:1481-1490
Aim: We performed a meta-analysis to explore the efficacy of immunotherapy for patients with squamous non-small-cell lung cancer (NSCLC). Materials & methods: Randomized clinical trials comparing immunotherapy with chemotherapy for advanced NSCLC pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94dcd012b5ba843be858b7584b37a869
https://doi.org/10.2217/imt-2019-0101
https://doi.org/10.2217/imt-2019-0101
Autor:
Yang Cao, Si Yu Wang, Zhi Wei Xiao, Li Zhu Lin, Xiao Jie Deng, Zhuang Zhong Chen, Jing Xu Zhou, Jie Tao Lin, Shan Su, Rui Lian Chen, Ling Ling Sun
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Background Limited treatment strategies are available for squamous-cell lung cancer (SQLC) patients. Few studies have addressed whether immune-related genes (IRGs) or the tumor immune microenvironment can predict the prognosis for SQLC patients. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da4854452c4b9c85bb9e0de88b9da92
http://europepmc.org/articles/PMC7533590
http://europepmc.org/articles/PMC7533590
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 35(2)
To study the predicting effect of proly 4-hydroxylase beta polypeptide (P4HB) in treating non-small cell lung cancer (NSCLC) patients by Yiqi Chutan Recipe (YCR).Totally 46 stage III and IV NSCLC patients were treated by YCR for 4 therapeutic courses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b20c355ffa4738223b00bff506f76f80
https://pubmed.ncbi.nlm.nih.gov/25881463
https://pubmed.ncbi.nlm.nih.gov/25881463
Publikováno v:
Chinese journal of integrative medicine. 21(9)
To investigate the role of prolyl 4-hydroxylase beta polypeptide (P4HB) expressed in lung carcinoma and the intervention effect of Yiqi Chutan Formula (, YQCTF).Lung carcinoma model was established by subcutaneously inoculating LEWIS lung carcinoma c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d0c4597753b1ed4514ed7bb4a15505
https://pubmed.ncbi.nlm.nih.gov/24382781
https://pubmed.ncbi.nlm.nih.gov/24382781
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 31(1)
To investigate the effects of Yiqi Chutan Recipe (YCR, a Chinese herbal prescription for invigorating qi and removing phlegm) on the growth and metastasis of tumor, survival time, and the expressions of peroxiredoxin (PRDX-1 and PRDX-6) in tumor tiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a60e05f4b6a2a808f1de5ffd46a20833
https://pubmed.ncbi.nlm.nih.gov/21434354
https://pubmed.ncbi.nlm.nih.gov/21434354
Autor:
Jing-xu, Zhou, Li-zhu, Lin
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 28(12)
Senile lung cancer has its own characteristics, thus its treatment is also particular. Viewing from the therapeutic angle of integrative medicine, the current status of research and application of various clinical treatment strategies and measures fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51018f7054add86ccbd5559dbe916689
https://pubmed.ncbi.nlm.nih.gov/19317175
https://pubmed.ncbi.nlm.nih.gov/19317175